Table 3 Factors associated with mastectomy in patients with very early breast cancera

From: Spectrum of very early breast cancer in a setting without organised screening

Characteristics

Mastectomy (n =591)

Breast conserving surgery (n =527)

Univariable odds ratio for mastectomy (95% CI)

Multivariable odds ratio for mastectomy b (95% CI)

Age, in years, medianc

55 (48,64)

49 (43,56)

1.05 (1.04–1.06)d

1.02 (1.01–1.04)d

Race, n (%)

Chinese

476 (57.6)

350 (42.4)

1.00

1.00

Malay

56 (35.9)

100 (64.1)

0.41 (0.29–0.59)d

0.41 (0.27–0.62)d

Indian

51 (45.9)

60 (54.1)

0.63 (0.42–0.93)d

0.55 (0.35–0.87)d

Others

8 (32.0)

17 (68.0)

0.35 (0.15–0.81)d

0.54 (0.21–1.40)

Marital status, n (%)

Married

491 (54.3)

414 (45.7)

1.31 (0.92–1.85)

Not married

70 (47.6)

77 (52.4)

1.00

Not known

30

36

 

Parity, n (%)

Nulliparous

86 (48.9)

90 (51.1)

1.00

1.00

1–2 children

162 (48.5)

172 (51.5)

0.99 (0.68–1.42)

0.77 (0.51–1.18)

3 children

283 (60.4)

175 (39.6)

1.69 (1.19–2.40)d

1.32 (0.87–2.00)

Unknown

60

90

  

Menopausal status, n (%)

Premenopausal

198 (39.6)

302 (60.4)

1.00

1.00

Postmenopausal

355 (63.7)

202 (36.3)

2.68 (2.09–3.44)d

1.96 (1.27–3.02)d

Unknown

38

23

  

Year of diagnosis, n (%)

1993–1997

37 (55.2)

30 (44.8)

1.00

1998–2002

89 (43.8)

114 (56.2)

0.63 (0.36–1.10)

2003–2007

215 (53.3)

188 (46.7)

0.93 (0.55–1.56)

2008–2011

248 (56.0)

195 (44.0)

1.03 (0.62–1.73)

Unknown

2

0

  

Tumour size, in cm, medianc

1.5 (1.0,2.0)

1.4 (0.8,1.7)

1.21 (1.02–1.45)d

1.22 (1.01–1.48)d

Lymphovascular invasion

Present

144 (57.4)

107 (42.6)

1.22 (0.91–1.64)

 

Absent

338 (52.4)

307 (47.6)

1.00

 

Unknown

109

113

  
  1. Abbreviations: CI=confidence interval; HER2=Human Epidermal Growth Factor Receptor 2.
  2. aIncluded patients with stage I breast cancer who underwent breast surgery.
  3. bUsing stepwise backward logistic regression. Variables entered on step 1 are those with P-values<0.20 in the Chi-square (categorical variable) or Mann–Whitney U (continuous variable) test, i.e., age at diagnosis, ethnicity, marital status, parity, menopausal status, year of diagnosis, tumour size, and lymphovascular invasion. The P-values for family history, tumour grade, oestrogen receptor status, progesterone receptor status and HER2 status were >0.20. Final model includes age at diagnosis, ethnicity, parity, menopausal status, and tumour size.
  4. c25th and 75th percentile values.
  5. dStatistically significant.